Life Technologies reported $1.84M in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
Ardelyx USD 206.64M 55.79M Jun/2025
Biogen USD 6.59B 296.8M Jun/2025
Bristol-Myers Squibb USD 50.93B 1.22B Jun/2025
Cipla INR 4.38B 231.9M Mar/2025
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.97M 58K Jun/2025
CSL USD 11.96B 219M Dec/2024
Galapagos EUR 10.86M 864K Mar/2025
GlaxoSmithKline GBP 17.35B 1.08B Jun/2025
Grifols EUR 9.23B 626.05M Dec/2024
Life Technologies USD 1.84M 416K Jun/2025
Novartis USD 31.27B 12M Mar/2025
Roche Holding CHF 34.44B 5.23B Jun/2024
United Therapeutics USD 200M 100M Mar/2025